|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/495 | (2006.01) |
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 2431039 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11193237.2 |
| Date of filing the European patent application | 2008-11-12 | |
| (97) | Date of publication of the European application | 2012-03-21 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-20 |
| (46) | Date of publication of the claims translation | 2016-10-10 |
| (30) | Number | Date | Country code |
| 200701607 | 2007-11-13 | DK | |
| 987710 P | 2007-11-13 | US | |
| 200701788 | 2007-12-14 | DK | |
| 13722 P | 2007-12-14 | US | |
| 200801300 | 2008-09-17 | DK | |
| 97840 P | 2008-09-17 | US |
| (72) |
Moore, Nicholas, US
Dragheim, Marianne, DK
Batra, Aneil, US
Chon, Jin, US
|
| (73) |
H. Lundbeck A/S,
Ottiliavej 9, 2500 Valby,
DK
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Junginių, turinčių jungtinį SERT, 5-HT3 ir 5-HT1A aktyvumą, terapiniai panaudojimai |
| Therapeutic uses of compounds having combined sert, 5-HT3 and 5-HT1A activity |
| Payment date | Validity (years) | Amount | |
| 2025-10-03 | 18 | 347.00 EUR |
| 2026-11-12 |